Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The closing price of Recursion Pharmaceuticals Inc (NASDAQ: RXRX) was $6.59 for the day, up 5.61% from the previous closing price of $6.24. In other words, the price has increased by $5.61 from its previous closing price. On the day, 19.13 million shares were traded.
Ratios:
Our analysis of RXRX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.81 and its Current Ratio is at 3.81. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.08.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Morgan Stanley on May 22, 2023, initiated with a Equal-Weight rating and assigned the stock a target price of $8.
On March 16, 2023, Needham started tracking the stock assigning a Buy rating and target price of $17.
On September 16, 2022, KeyBanc Capital Markets started tracking the stock assigning a Overweight rating and target price of $20.KeyBanc Capital Markets initiated its Overweight rating on September 16, 2022, with a $20 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 05 ’25 when Gibson Christopher sold 20,000 shares for $6.58 per share. The transaction valued at 131,600 led to the insider holds 1,256,024 shares of the business.
Gibson Christopher sold 20,000 shares of RXRX for $127,400 on Mar 06 ’25. The Chief Executive Officer now owns 1,256,024 shares after completing the transaction at $6.37 per share. On Mar 06 ’25, another insider, Gibson Christopher, who serves as the Officer of the company, bought 20,000 shares for $6.37 each.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 45.02 while its Price-to-Book (P/B) ratio in mrq is 2.53.
Stock Price History:
Over the past 52 weeks, RXRX has reached a high of $12.36, while it has fallen to a 52-week low of $5.60. The 50-Day Moving Average of the stock is -13.30%, while the 200-Day Moving Average is calculated to be -10.72%.
Shares Statistics:
A total of 389.55M shares are outstanding, with a floating share count of 305.79M. Insiders hold about 23.93% of the company’s shares, while institutions hold 60.16% stake in the company.
